Advertisement

Topics

Onxeo Appoints Seasoned Executives to Accelerate Preclinical and Clinical Development

12:00 EST 1 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Françoise Bono, PhD, Named Chief Scientific Officer to Lead Preclinical Activities Olivier de Beaumont, MD, MBA, Appointed Chief Medical Officer to Lead Clinical Development and Operations, Medical and Regulatory Affai...

Other Sources for this Article

Onxeo
Valerie Leroy,
Investor Relations
investors@onxeo.com
+33 1 45 58 76 00
or
Media Relations
Caroline Carmagnol / Simon Derbanne - Alize RP
onxeo@alizerp.com
+33 6 64 18 99 59 / +33 6 38 16 26 41
or
Investor Relations / Strategic Communications
Dušan Orešanský / Emmanuel HuynhNewCap
onxeo@newcap.eu
+33 1 44 71 94 92
or
Investor & Media Relations US
Kirsten Thomas / Lee Roth – The Ruth Group
kthomas@theruthgroup.com / lroth@theruthgroup.com
+1 508 280 6592 / +1 646 536 7012

NEXT ARTICLE

More From BioPortfolio on "Onxeo Appoints Seasoned Executives to Accelerate Preclinical and Clinical Development"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...